One Wisconsin Now
Press Release

Another Attorney General Not Named Brad Schimel Sues Opioid Manufacturer

Republican Attorney General in Colorado Alleges Purdue Pharma ‘Fraudulent and Deceptive’ Practices Helped Create Opioid Crisis

By - Sep 15th, 2018 08:00 am
Brad Schimel. Photo from the State of Wisconsin.

Brad Schimel. Photo from the State of Wisconsin.

MADISON, Wis. — The Republican Attorney General of Colorado is suing Purdue Pharma, alleging the drug manufacturer engaged in the “fraudulent and deceptive marketing of prescription opioids.” One Wisconsin Now Executive Director Scot Ross noted that fellow Republican Attorney General Brad Schimel continues to refuse to join the growing, bipartisan groups of state top cops taking opioid manufacturers to court over their role in the crisis of prescription painkiller addiction.

“With another Attorney General taking legal action against Purdue Pharma, this time Colorado’s Republican AG, there is no compelling legal case for Brad Schimel’s continuing refusal to hold manufacturers accountable for their actions that helped create the crisis of opioid addiction,” said Ross. “He’s isn’t doing anything because he simply doesn’t want to.”

Schimel has received campaign funds from opioid manufacturer Purdue Pharma. In addition, Purdue was a top five contributor to the Republican Attorneys General Association (RAGA) in 2016, the latest year for which data is available, chipping in over $505,000. RAGA has run multiple ads to try to boost Schimel as he faces election in November. Schimel’s top ally, Republican Gov. Scott Walker, also received a $10,000 contribution from Purdue Pharma founder Mort Sackler.

Meanwhile, numerous other states, represented by both Democratic and Republican Attorneys General, have gone to court over the alleged deceptive and misleading marketing practices minimizing risks and encouraging the over prescription of highly addictive opioid painkillers.

A New York Times story reveals principals at Purdue Pharma, the manufacturer of opioid painkiller oxycontin, knew about the dangers of abuse of their drug as early as 1996 and covered it up. The report also features federal officials expressing regret about how failing to aggressively prosecute pharmaceutical executives, “… meant that a critical chance to slow the trajectory of the opioid epidemic was lost.”

Despite Schimel’s lack of leadership in Wisconsin, 71 of the 72 counties in the state have either authorized or filed lawsuits against opioid manufacturers. Ross noted the action of local governments is with good reason, as a recently released report from the Centers for Disease Control and Prevention reveals Wisconsin is among the the worst states in the nation for increases in deaths attributable to opioids.

One Wisconsin Now is a statewide communications network specializing in effective earned media and online organizing to advance progressive leadership and values.

More about the Opioid Crisis

Mentioned in This Press Release

Organizations:

Recent Press Releases by One Wisconsin Now

One Wisconsin Now

Free Speech Crackdown on Agenda for University of Wisconsin Board of Regents Meeting

Regents Seem More Interested in Pandering to Right-Wing Politicians Than Protecting Free Speech

One Wisconsin Now

Crises Collide: Low Teacher Pay Intensifies Student Loan Debt Crisis for Educators

Financial Pressures Weigh on Teachers Considering Quitting and Debt Discourages Students From Pursuing Careers in K-12 Education

One Wisconsin Now

Unsealed Memo Exposes Student Loan Servicer Navient Pushing Payment Plans Driving Borrowers Deeper Into Debt

Another Example System Stacked Against Borrowers and Why Reform Desperately Needed

Leave a Reply

You must be an Urban Milwaukee member to leave a comment. Membership, which includes a host of perks, including an ad-free website, tickets to marquee events like Summerfest, the Wisconsin State Fair and the Florentine Opera, a better photo browser and access to members-only, behind-the-scenes tours, starts at $9/month. Learn more.

Join now and cancel anytime.

If you are an existing member, sign-in to leave a comment.

Have questions? Need to report an error? Contact Us